Centogene expands executive leadership team

Centogene announced the expansion of its executive leadership team with the appointment of philip lambert, phd in cambridge, ma as chief scientific officer. with more than two decades of experience in the global drug discovery and pre-clinical development sectors, philip will have the overall responsibility of driving scientific programs to align with the needs of pharmaceutical partners. in parallel to this appointment, prof. peter bauer, md will take on the role of chief genomic officer, directing centogene’s genomic programs. philip joins centogene from life biosciences, a global company focused on extending the healthy lifespan of individuals by investigating eight biological pathways believed to increase longevity. he served as senior vice president of discovery and labs as well as chief operating officer of two subsidiary companies, selphagy therapeutics and spotlight biosciences. prior to life biosciences, philip served as scientific partner and head of discovery at charles river laboratories, where he was responsible for establishing scientific credibility and delivering the business to client companies and venture capital firms. philip also co-founded vivopath, a preclinical screening company, offering clients discovery and development services for proof-of-concept testing.
CNTG Ratings Summary
CNTG Quant Ranking